http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04178372-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 1990-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c592164664c3d6ce7bc90f41957d1f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_734a554a3d72276ea22738a3bdd6938d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04dbdb20c6db7d9059d8a9ac61665151
publicationDate 1992-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04178372-A
titleOfInvention New hexane derivative and production thereof
abstract NEW MATERIAL:A compound expressed by formula I (B is nucleic acid base derivative; R is H, acyl or phosphate group or protecting group). n EXAMPLE: (±)-9-(1,6-Dihydroxy-3-hexyl)adenine. n USE: An antiviral agent and anticancer agent. n PREPARATION: A compound expressed by formula II (X is eliminating group) is reacted with a nucleic acid base derivative (e.g. adenine) as necessary in the presence of a base catalyst (e.g. potassium carbonate), in a solvent such as DMF at 0°C to temperature capable of refluxing the solvent to afford a compound expressed by formula III (B 1 is nucleic acid base derivative which may be protected). Then, as necessary, a protecting group thereof is removed or replaced by other protecting group to provide the compound expressed by formula I. n COPYRIGHT: (C)1992,JPO&Japio
priorityDate 1990-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415969487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67892821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235000866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235000867

Total number of triples: 42.